A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.
Clinical trial NCT07543224 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07543224
- Sponsor
- Reistone Biopharma Company Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-01-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.